26 Apr 2006

UCB: Two European Regulatory Milestones for Keppra®

Read More
24 Apr 2006

UCB transfers back to Recordati the rights for the sale of Corifeo® (Lercanidipine) in Germany

Read More
31 Mar 2006

UCB - 2005 Annual Report on-line

Read More
31 Mar 2006

UCB - 2005 Annual Report on-line

Read More
14 Mar 2006

UCB - live analyst presentation

Read More
14 Mar 2006

UCB Full-Year 2005 Financial Results

Read More
2 Mar 2006

UCB Submits Biologics License Application to FDA for New Treatment in Crohn's Disease

Read More
23 Feb 2006

UCB Licenses Sepracor U.S. patents for antihistamine Levocetirizine

Read More
3 Feb 2006

UCB Receives EMEA Positive Opinion and FDA Approvable Letter for Keppra® (levetiracetam) Intravenous Administration

Read More
19 Jan 2006

UCB confirms good 2005 performance of Zyrtec in US and Xyzal

Read More
Subscribe to